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INTRODUCTION   
At	 level	 of	 intestine	 is	 very	 important	 the	
equilibrium	 between	 the	 intestinal	 microflora	
and	the	host.	Many	factors	can	affect	the	intestinal	
microbial	ecology:	diseases,	nutrition,	treatments,	
stress,	living	condition	(Gibson	and	Fuller,	2000).	
For	maintaining	 of	 the	 intestinal	 microflora	 and	
the	health	of	 animals,	 one	 alternative	 is	using	of	
probiotic,	prebiotic,	and	synbiotic	products.	
Probiotics	 are:	 “live	 microorganisms	 which,	
when	 consumed	 in	 adequate	 amounts,	 confer	 a	
health	benefit	on	the	host”	(Guarner	and	Schaafsm,	
1998;	FAO,	2002;	Donohue,	2006).
Prebiotics	 can	 be	 defined	 as	 “nondigestible	
food	 ingredients	 that	 beneficially	 affect	 the	 host	
by	 selectively	 stimulating	 the	growth	and/or	 the	
activity	 of	 one	 or	 a	 limited	 number	 of	 bacterial	
species	 already	 resident	 in	 the	 colon,	 and	 thus	
attempt	 to	 improve	 host	 health”	 (Gibson	 and	
Roberfroid,	 1995;	 Schrezenmeir,	 and	 de	 Vrese,	
2001).	
The	 synbiotic	 is	 a	 product	 that	 contains	
both	 prebiotic(s)	 and	 probiotic(s).	 These 
food	 supplements	 have	 numerous	 and	 complex	
effects	 on	 the	 intestinal	 microbiota	 and	 gut	
immune	system	(Gourbeyre et al.,	2011).
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Abstract
The	 study	 aims	 was	 to	 visualize	 the	 effect	 of	 dietary	 supplements	 (probiotics,	 prebiotics,	 synbiotics)	 on	
clinically	healthy	animals	and	comparative	analysis	of	hematological	and	microbiological	parameters.
Were	administered	daily	in	four	groups	of	five	male	mice	(about3-4	months),	probiotics	-	group	1	(Eubiotic	
1g/b.w.),	prebiotic	-	group	2	(Lactulose	0.66	gram/kg	body	weight),	symbiotic	-	group	3(combination	of	Eubiotic	and	
Lactulose)	and	distillated	water	-	group	4	(control	group).	Before	administration	and	13	days	after	administration	
microbiological	samples	were	taken	from	the	rectum,	hematological	analyses	were	performed	(blood	cells	count,	
white	 blood	 cells	 differential	 and	 blood	 glucose	 level);	 blood	was	 collected	 from	 the	 retrobulbar	 sinus	 under	
anaesthesia	with	chloroform.
The	 total	 number	 of	 red	 blood	 cells	 was	 3.15	 and	 6.3	 T/L	 and	 the	WBC	 3.05	 and	 8.25	 G/L	 respectively.	
Administration	of	 the	probiotic	determined	 stimulation	of	 the	 immune	 system	by	 increasing	 the	 total	number	
of	white	blood	cell,	increasing	of	the	number	of	intestinal	bacterial	species	and	decreasing	of	CFU.	The	prebiotic	
produced	not	significant	changes	of	the	parameters	analysed.	In	the	case	of	the	symbiotic	the	change	was	due	to	
the	probiotic	dose,	post-treatment	differences	are	similar	to	those	in	group	1	(treated	with	probiotic)	but	not	so	
intense.
In	 the	 present	 research	work,	we	 observed	 that	 administration	 of	 pro-	 and	 prebiotics	 has	 not	 negatively	
influenced	the	health	of	animals.	The	probiotic	produced	the	most	significant	growth	rate,	achieved	with	a	superior	
feed	conversion	rate.
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The	 study	 aims	 was	 to	 visualize	 the	 effect	
of	 dietary	 supplements	 (probiotics,	 prebiotics,	
synbiotics)	 on	 clinically	 healthy	 animals	 and	
comparative	 analysis	 of	 hematological	 and	
microbiological	parameters.
MATERIALS AND METHODS   
Treatments
The	 probiotic	 used	 was	 a	 product,	 which	
contained	 live	 bacterial	 cultures	 -	 250X106CFU:	
Bifidobacterium	BB-12,	Lactobacilus paracasei	43;	
Streptococcus thermophilus	TH4.
The	 prebiotic	 was	 lactulose	 that	 is	 a	
disaccharide	 synthetized	 from	 fructose	 and	
galactose.	This	substance	is	used	for	effect	on	the	
gastrointestinal	system:	control	of	gastric	acidity,	
regulated	 gastrointestinal	 motility	 and	 water	
flow.	 Also,	 is	 able	 to	 simulate	 healthy	 intestinal	
microflora.
The	 synbiotic	 was	 the	 combination	 of	 pro-
biotic	 and	 prebiotic,	 and	 was	 used	 because	 the	
symbiotic	 stimulate	 and	 increase	 the	 survival	 of	
probiotic	 and	 autochthonous-specific	 strains	 in	
the	intestinal	tract.
Animals and protocol
Male	 mice	 (N	 =	 20,	 age	 12	 weeks),	 were	
randomly	 divided	 into	 4	 groups:	 PROB,	 PREB,	
SYNB,	 CRLT.	 The	 administration	 of	 the	 products	
was	made	 by	 gastric	 gavage	 in	 0.5	ml	 distillated	
water,	daily.	
In	 PROB-treated	 group,	 mice	 were	 treated	
with	 0.03	 g	 probiotic	 (2.14x106CFU/animal).	
In	 PREB-treated	 group,	 mice	 received	 0.01g	
lactulose/animal.	The	SYNB	group	received	0.015	
g	 probiotic	 (1.7x106CFU/animal)	 in	 combination	
with	0.007	g	lactulose/animal.	The	CRLT	was	the	
negative	 group	 and	 was	 administrated	 0.5	 ml	
distillated	water/animal.
Animals	were	kept	 in	separate	cage	 for	each	
group,	 in	 a	 controlled	 environment	 with	 12:12	
light-dark	cycle	and	ad	libitum	access	to	water	and	
food.	
Administration	of	products,	body	weight	and	
food	 intake	 (quantity	 of	 food)	 were	 monitored	
every	day,	for	12	days.	
I	 days	 1	 and	 13	 of	 the	 study	were	 collected	
blood	samples	for	hematology	and	rectal	samples	
for	microbiology.
The	study	was	performed	with	the	agreement	
of	 bioethics	 comity	 of	 Faculty	 of	 Veterinary	
Medicine	Cluj	and	according	with	the	EU	regulation	
concerning	laboratory	animal	welfare.
Hematological analysis
For	 hematological	 investigation,	 blood	 was	
collected	 (with	 heparin)	 from	 retrobulbar	 sinus	
under	anesthesia	with	chloroform.	Hematological	
analyzes	were	the	following:	determination	of	total	
number	of	erythrocytes	and	leucocytes,	leukocyte	
formula	and	blood	glucose	level	(Tab.	1).
Microbiological analysis
For	the	microbiological	examination	of	rectal	
samples	 was	 used	 cultivation	 on	 the	 different	
culture	mediums:	blood	agar,	MacConkey	agar	and	
glucose	agar.	Bacteria	were	counted	and	identified	
hemolysis	test,	catalase	and	oxidase	tests.
Growth performance
All	mice	were	weighed	 individually	 in	 every	
day.	Daily	weight	gain	for	each	dietary	treatment	
was	 calculated.	 Feed	 consumption	was	 recorded	
in	 the	 course	 of	 the	 whole	 experiment	 for	 each	
treatment,	and	the	feed	conversion	rate	(FCR)	was	
calculated	subsequently.
Statistical analysis
Statistical	 analyses	were	 conducted	with	 the	
GraphPad	InStat	to	determine	if	variables	differed	
between	 groups.	 The	 Kolmogorov-Smirnov	 test	
was	 used	 to	 test	 the	 nor	mal	 distribution	 of	 the	
data	 before	 statistical	 analysis	 was	 performed.	
Results	 are	 expressed	 as	 means	 ±	 SD.	 All	 the	
investigated	parameters	were	compared	between	
groups	by	one-way	ANOVA	and	subsequent	Welch	
ŞTEFĂNUŢ	et al
Tab. 1 The	methods	used	for	hematological	investigation
Nr.	crt INVESTIGATED	PARAMETERS METHOD
UNIT	OF	
MEASUREMENT
1. Red	Blood	Cells	count Hemocytometer	method T/L
2. White	Blood	Cells	count Hemocytometer	method G/L
3. Blood	glucose Glucometer mg/dl
4. White	Blood	Cells	differential Blood	smears	-	stain	DQP %
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test.	Probability	values	of	less	than	0.05	(P	<	0.05)	
were	considered	significant.
RESULTS AND DISCUSSION  
Hematological analysis
We	observed	 the	decreasing	of	 total	number	
of	erythrocytes	(Tab.	2)	to	all	the	groups,	but	the	
level	of	this	parameter	was	between	physiological	
limits.	The	most	important	decreasing	was	to	CRLT	
group,	in	this	case	the	differences	was	significant	
(P	<	0.05).
We	 monitored	 the	 level	 of	 total	 number	 of	
leucocytes.	The	relevant	difference	was	observed	in	
case	of	administration	of	probiotic	(PROB-group)	
which	produced	the	significant	increase	(P	<	0.05) 
of	 total	 leukocytes;	 the	 level	 of	 this	 parameter	
was	 3.99	±1.481	 G/L	 for	 first	 determination	 and	
7.73±1.70	G/L	 for	 the	end	of	 the	study.	Also,	 the	
increasing	 of	 total	 leukocytes	 was	 important	
for	 SYNG-group	 (3.87±1.0	 G/L	 –	 6.66±3.0	 G/L)	
(Tab.	2).	Comparative	evaluation	of	blood	glucose	
levels	 revealed	 significant	 increases	 (between	
physiological	 limits)	 for	 the	groups	PROB,	PREB,	
SYNB,	and	decreases	 in	case	of	CRLT	group	(Tab.	
2).
The	 leukocytes	 subpopulations	 analyze,	
revealed	 the	 differences	 between	 the	 groups	 at	
the	end	of	the	experiment.		The	significant	change	
for	 the	 PROB-group	 was	 the	 decrease	 of	 the	
monocytes.	 In	 case	 of	 PREB-group,	we	 observed	
the	increasing	of	the	eosinophils	and	the	evolution	
for	SYNB-group	was	characterized	by	the	increase	
of	 the	neutrophils	with	decreasing	of	monocytes	
(Tab.	3).	
Microbiological examination
Administration	of	the	probiotic	and	prebiotic	
produced,	 generally,	 changes	 in	 the	 intestinal	
microbial	 communities.	 In	 our	 study,	 in	 the	
microbial	 population	 were	 predominant	 the	
following	 bacterial	 species:	 Escherichia coli,	
Enterococccus faecalis,	 Staphylococccus spp.,	
Micrococcus	 spp.,	Bacillus	 spp.	 At	 the	 end	 of	 the	
study,	we	observed	important	differences	between	
the	groups	of	animals	and	the	moment	of	samples	
collection.	 In	 case	 of	 PROB-group,	 we	 observed	
increasing	 of	 number	 of	 bacterial	 species	 with	
decreasing	of	CFU.	Increasing	of	bacterial	species	
Tab. 3	Leucocytes	formula	(average	±	SD)	of	the	experimental	group
GROUPS
LEUCOCYTES
Neutrophils	(%) Eozinophiles	(%) Basophiles	(%) Lymphocytes	(%) Monocytes	(%)
Day	1 Day	13 Day	1 Day	13 Day	1 Day	13 Day	1 Day	13 Day	1 Day	13
PROB 41	±2.74
47
±11.60
6.8
±3.27
8,6
±4.22
0 0
40
±6.60
36.6
±13.07
11.6
±1.34
7.2*
±	2.17
PREB
38.4	
±12.40
49
±4.24
2.6
±1.82
6.8*
±3.03
0 0
48.8
±10.55
37.4
±2.79
10.2
±4.76
6.0
±1.41
SYNB
36.8	
±6.76
49*
±7.97
6.6
±2.79
6.4
±3.13
0 0
40.0
±2.0
35.8
±7.43
16.16
±4.16
8.8*
	±	2.59
CRLT
39.75	
±3.30
53.5
±12.12
3.75
±2.22
7.5
±5.69
0 0
45.75
±6.99
31*
±11.20
45.75
±6.99
8.0
±4.97
PROB=probiotic;	PREB=prebiotic;	SYNB=synbiotic;	CRLT=control;	*=significant	difference	(p<0.05)
Tab. 2	Hematological	investigated	parameters	(average	±	SD)	of	the	experimental	group
GROUPS
PARAMETERS
Erythrocytes	(T/L) Leucocytes	(G/L) Blood	glucose	(mg/dl)
Day	1 Day	13 Day	1 Day	13 Day	1 Day	13
PROB 3.98±2.59 3.53+1.99 3.99±1.48 7.73±1.70* 95.4±19.69 152±37.06*
PREB 4.92±0.83 4.11±0.52 3.93±0.64 3.84±1.21 106.4±20.82 161.4±31.66
SYNB 5.49±0.67 3.82±0.73 3.87±1.0 6.61±3.05 99±18.88 123.2±27.22
CRLT 5.33±2.38 3.58±1.48* 6.18±2.63 6.32±1.81 108±28.16 83.25±24.49
PROB=probiotic;	PREB=prebiotic;	SYNB=synbiotic;	CRLT=control;	*=significant	difference	(p<0.05)
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is	linked	to	the	composition	(bacterial	structure)	of	
probiotic	product.	Administration	of	prebiotic	has	
caused	increasing	of	CFU,	with	the	maintenance	of	
a	constant	level	of	bacterial	species.	The	symbiotic	
has	 the	 same	 effect	 as	 the	 prebiotic.	 In	 case	 of	
CRLT	group,	 the	number	of	bacterial	species	and	
CFU	were	constant	in	the	two	moments	of	analysis	
(first	day	and	last	day	of	the	study).
Growth performance
The	 initial	 body	 weight	 of	 mice	 did	 not	
differ	between	groups.	At	the	end	of	experiment,	
mice	 treated	with	pro-,	pre-	and	symbiotic	has	a	
greater	body	weight	compared	with	control.	Feed	
conversion	 rate	 (FCR)	 was	 low	 for	 PROB-group	
(8.68)	 than	 CRLT-group	 (8.81)	 and	 PREB-group	
(8.97)	and	SYNB-group	(12.3)	(Tab.	4).
The	 beneficial	 effects	 of	 pre-,	 pro-,	 and	
symbiotic	products		can	be	based	on	the	ability	to	
change	the	composition	of	bacterial	communities	
in	 gastrointestinal	 tract	 (GIT)	 biofilm	 and	 on	
displacement	 of	 pathogenic	 microorganisms	
and/or	modification	of	immune	system	reactions	
through	 different	 mechanisms	 (de	 Vrese	 and	
Schrezenmeir,	2008).	All	these	effects	are	based	on	
the	characteristic	properties	of	each	product.	
Probiotics	 can	 directly	 inhibit	 the	 growth	 of	
pathogens	by	producing	antibacterial	substances,	
including	 bacteriocins	 (such	 as	 antibiotics)	 and	
different	acids	 (acetic,	 lactic,	and	propionic	acid)	
(Cotter	et al.,	2005;	Servin,	2004).	They	can	also	
decrease	 the	 adhesion	 of	 pathogens	 and	 their	
toxins	 to	 the	 gastrointestinal	 tract	 through	 their	
ability	 to	 adhere	 to	 intestinal	 epithelial	 cells.	
Gourbeyre	 et al.	 (2011)	 show	 that	 probiotic	
bacteria	can	enhance	the	integrity	of	the	intestinal	
barrier.	 Probiotics	 are	 able	 to	 exert	 an	 impact	
on	 the	 intestinal	 environment	 through	 different	
key	 non-immune	 mechanisms	 (Gourbeyre	 et al.,	
2011).	
The	principal	effect	of	prebiotic	 is	 related	 to	
the	metabolism	 of	 the	microbiota	 (Gourbeyre	 et 
al.,	 2011).	 	 Prebiotics	 are	 selectively	 fermented	
ingredients	 that	 allow	 specific	 changes	 both	
in	 the	 composition	 and/or	 in	 the	 activity	 of	
gastrointestinal	microflora.	Their	exact	mechanism	
of	action	is	still	unclear.	Apparently	they	are	able	
to	 increase	 the	 production	 of	 small	 chain	 fatty	
acid	(SCFA)	and	to	modulate	cytokines	production	
within	the	gut	mucosa,	by	modulating	the	gut	flora	
composition	(Scaldaferri	et al.,	2013).
A	combination	of	probiotic(s)	and	prebiotic(s)	
constitutes	 a	 synbiotic	 (Gourbeyre	 et al.,	 2011;	
Gibson	 and	Roberfroid,	 1995;	 Fooks	 and	Gibson,	
2002),	 which	 can	 stimulate	 and	 increase	 the	
survival	 of	 probiotic	 and	 autochthonous-specific	
strains	in	the	intestinal	tract.
Gourbeyre	 et al.	 (2011)	 revealed	 that	
probiotics	 and	 prebiotics,	 alone	 or	 together	
(synbiotics),	 can	 influence	 the	 intestinal	
microbiota	 and	modulate	 the	 immune	 response.	
Prebiotic	and	probiotic	have	effects	on	the	innate	
and	 adaptive	 immune	 responses.	 A	 nonspecific	
effect	 through	 the	 stimulation	 of	 innate	 immune	
cells	produced	increase	in	the	cytotoxic	activity	of	
NK	cells	and	macrophage	phagocytosis.	
Generally,	 the	 growth	 performance	 and	 feed	
efficiency	are	 induced	by	the	total	effects	of	pro-	
and	prebiotics,	 including	maintenance	of	 normal	
ecology	of	intestinal	microflora	and	increasing	of	
feed	intake	and	digestion	(Awad	et al.,	2009).
CONCLUSION
The	 analysis	 of	 the	 results	 reveals	 that	 the	
administration	of	pro-,	pre-,	and	synbiotic	did	not	
have	negative	effect	on	the	health	of	animals.	Also,	
were	observed	different	aspects	depending	on	the	
parameters	investigated	and	experimental	group:
1.	 The	 probiotic	 determined:	 stimulation	 of	 the	
immune	 system	 by	 increasing	 of	 the	 total	
number	 of	 leukocytes;	 increasing	 of	 intestinal	
bacterial	 species	 with	 decreasing	 of	 CFU;	 the	
largest	increase	of	body	weight	with	a	superior	
feed	conversion	rate.
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Tab. 4	Feed	consumption,	average	gain	and	feed	conversion	rate	of	the	experimental	group
FEED	CONSUMPTION	(g) AVERAGE	GAIN	(g) FEED	CONVERSION	RATE	
PROB 295 34.00 8.68
PREB 278 31.00 8.97
SYNB 283 23.00 12.30
CRLT 238 27.00 8.81
PROB=probiotic;	PREB=prebiotic;	SYNB=synbiotic;	CRLT=control
305
Bulletin UASVM Veterinary Medicine 72 (2) / 2015
2.	The	probiotic	did	not	cause	significant	changes	
to	the	investigated	parameters.	
3.	 In	 the	 case	 of	 symbiotic,	 the	 changes	 were	
due	 by	 the	 probiotic	 dose,	 post-treatment	
differences	 were	 similar	 to	 those	 obtained	
after	administration	of	the	probiotic,	but	not	so	
intense.
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